2 Clinical Trials for Various Conditions
To investigate bevacizumab in combination with carboplatin and capecitabine for patients with unresectable or metastatic GEJ or gastric cancers. We hope that by adding bevacizumab to standard chemotherapy for this patient population we will improve Progression Free Survival by 90% over historical controls.
The purpose of this study is to see whether giving azacitidine before each cycle of chemotherapy prior to surgery is safe.